---
title: "Definitive Healthcare Corp. (DH.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/DH.US.md"
symbol: "DH.US"
name: "Definitive Healthcare Corp."
industry: "Health Care Technology"
---

# Definitive Healthcare Corp. (DH.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Location | US Market |
| Website | [www.definitivehc.com](https://www.definitivehc.com) |

## Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from prod...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: D (0.67)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 38 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -5.30% |  |
| Net Profit YoY | 48.20% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.78 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 222.39M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 242.28M |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -47.69% | E |
| Profit Margin | -77.88% | E |
| Gross Margin | 84.90% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -5.30% | D |
| Net Profit YoY | 48.20% | B |
| Total Assets YoY | -36.06% | E |
| Net Assets YoY | -43.98% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -128.40% | D |
| OCF YoY | -5.30% | D |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.25 | D |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 48.42% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Definitive Healthcare Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-47.69%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-77.88%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "84.90%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-5.30%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "48.20%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-36.06%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-43.98%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-128.40%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-5.30%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.25",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "48.42%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B |
| 02 | Waystar (US.WAY) | C | A | D | B | B | B |
| 03 | Doximity (US.DOCS) | A | B | C | A | C | B |
| 04 | Phreesia (US.PHR) | C | B | A | B | D | B |
| 05 | HealthStream (US.HSTM) | B | C | B | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.18 | 19/42 | - | - | - |
| PB | 0.78 | 7/42 | 1.77 | 1.21 | 0.95 |
| PS (TTM) | 0.92 | 12/42 | 2.28 | 1.59 | 1.25 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-14T05:00:00.000Z

Total Analysts: **12**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 25% |
| Overweight | 0 | 0% |
| Hold | 8 | 67% |
| Underweight | 1 | 8% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.55 |
| Highest Target | 6.00 |
| Lowest Target | 2.75 |

## References

- [Company Overview](https://longbridge.com/en/quote/DH.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/DH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/DH.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.